Pyruvate delays WD by inhibiting the activation of poly-ADP ribose polymerase 1 (PARP-1), which results in NAD+ depletion and inhibition of glycolysis (Zilberter et al., 2015). This evidence concerns the gene PARP1 and Wilson disease.